Biologics and Infections: Lessons from Tumor Necrosis Factor Blocking Agents-Reference-Cited by-同舟云学术

Biologics and Infections: Lessons from Tumor Necrosis Factor Blocking Agents

Published:2011-12 Issue:4 Volume:25 Page:895-910
ISSN:0891-5520
Container-title:Infectious Disease Clinics of North America
language:en
Short-container-title:Infectious Disease Clinics of North America

Author:

Wallis Robert S.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference96 articles.

1. Humira prescribing information,2007

2. Infliximab (Remicade®) prescribing information,2008

3. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement;Baughman;Am J Respir Crit Care Med,2006

4. Effectiveness of infliximab in treating selected patients with sarcoidosis;Saleh;Respir Med,2006

5. A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis;Rossman;Sarcoidosis Vasc Diffuse Lung Dis,2006

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adalimumab-Induced Isolated Peritoneal Tuberculosis;International Journal of Recent Surgical and Medical Sciences;2023-04-04

2. Infectious Complications of Pediatric Inflammatory Bowel Disease;Pediatric Inflammatory Bowel Disease;2023

3. Management of Psoriatic Erythroderma with Ayurvedic herbomineral preparations: A case report;Journal of Ayurveda and Integrative Medicine;2022-04

4. The Risk of Systemic Diseases in Those with Psoriasis and Psoriatic Arthritis: From Mechanisms to Clinic;International Journal of Molecular Sciences;2020-09-24

5. The Effects of Rheumatoid Arthritis on In-Hospital Lengths of Stay, Complications, and Costs following Primary Total Hip Arthroplasty: A Matched-Control Study;The Journal of Hip Surgery;2020-09